Microbiota-derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo - PubMed (original) (raw)
doi: 10.1111/nmo.13178. Epub 2017 Aug 7.
Affiliations
- PMID: 28782205
- DOI: 10.1111/nmo.13178
Microbiota-derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo
M Jennis et al. Neurogastroenterol Motil. 2018 Feb.
Abstract
Background: The diet and microbiome contribute to metabolic disease in part due to increased intestinal inflammation and permeability. Dietary tryptophan is metabolized by both mammalian and bacterial enzymes. Using in vitro, in vivo models, and clinical data, we tested whether bacterial tryptophan indole derivatives underlie the positive benefits of microbiota on inflammation that is associated with metabolic disease.
Methods: In high-fat diet (HFD)-fed mice intestinal permeability and plasma endotoxin levels were measured after indole-3-propionic acid (IPA; 20 mg kg-1 p.o. for 4 days). Tryptophan derivatives effect on permeability and gene expression were assessed in T84 intestinal cell monolayers, in the presence or absence of pro-inflammatory cytokines. Plasma tryptophan metabolites were analyzed from lean, or obese T2D subjects undergoing Roux-en-Y gastric bypass surgery (RYGB).
Key results: IPA reduced the increased intestinal permeability observed in HFD-fed mice. Of 16 metabolites tested in vitro, only IPA, and tryptamine reduced T84 cell monolayer permeability compromised by pro-inflammatory cytokines. In T84 cells, IPA reversed the IFN-γ induced increase of fructose transporter SLC2A5 (GLUT5) mRNA, but not induction of inflammatory or metabolic genes. In obese subjects, IPA levels were reduced relative to lean counterparts, and these levels were increased by 3 months after RYGB.
Conclusions and inferences: The novel findings are that obese subjects have lower levels of IPA, a solely bacterially derived tryptophan derivative, and IPA improved intestinal barrier function in vitro and DIO mice. Reduced plasma IPA levels and reversal by surgery may be a consequence of intestinal indole-producing microbiota but underlying mechanisms warrant further investigation.
Keywords: T84 cell monolayer; diet-induced obese mice; indole-3-propionic acid; microbiome; tryptamine; tryptophan.
© 2017 John Wiley & Sons Ltd.
Similar articles
- Beneficial actions of microbiota-derived tryptophan metabolites.
Galligan JJ. Galligan JJ. Neurogastroenterol Motil. 2018 Feb;30(2). doi: 10.1111/nmo.13283. Neurogastroenterol Motil. 2018. PMID: 29341448 Review. - Navy bean supplemented high-fat diet improves intestinal health, epithelial barrier integrity and critical aspects of the obese inflammatory phenotype.
Monk JM, Wu W, Lepp D, Wellings HR, Hutchinson AL, Liddle DM, Graf D, Pauls KP, Robinson LE, Power KA. Monk JM, et al. J Nutr Biochem. 2019 Aug;70:91-104. doi: 10.1016/j.jnutbio.2019.04.009. Epub 2019 May 10. J Nutr Biochem. 2019. PMID: 31195365 - Roux-en-Y gastric bypass potentially improved intestinal permeability by regulating gut innate immunity in diet-induced obese mice.
Jin Z, Chen K, Zhou Z, Peng W, Liu W. Jin Z, et al. Sci Rep. 2021 Jul 21;11(1):14894. doi: 10.1038/s41598-021-94094-8. Sci Rep. 2021. PMID: 34290269 Free PMC article. - Interplay between gut microbiota and tryptophan metabolism in type 2 diabetic mice treated with metformin.
Xie Y, Li X, Meng Q, Li J, Wang X, Zhu L, Wang W, Li X. Xie Y, et al. Microbiol Spectr. 2024 Oct 3;12(10):e0029124. doi: 10.1128/spectrum.00291-24. Epub 2024 Aug 20. Microbiol Spectr. 2024. PMID: 39162538 Free PMC article. - Emerging effects of tryptophan pathway metabolites and intestinal microbiota on metabolism and intestinal function.
Hyland NP, Cavanaugh CR, Hornby PJ. Hyland NP, et al. Amino Acids. 2022 Jan;54(1):57-70. doi: 10.1007/s00726-022-03123-x. Epub 2022 Jan 17. Amino Acids. 2022. PMID: 35038025 Review.
Cited by
- Tryptophan Metabolism Disorder-Triggered Diseases, Mechanisms, and Therapeutic Strategies: A Scientometric Review.
Chen X, Xu D, Yu J, Song XJ, Li X, Cui YL. Chen X, et al. Nutrients. 2024 Oct 4;16(19):3380. doi: 10.3390/nu16193380. Nutrients. 2024. PMID: 39408347 Free PMC article. Review. - Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis.
Koutoukidis DA, Yen S, Gomez Castro P, Misheva M, Jebb SA, Aveyard P, Tomlinson JW, Mozes FE, Cobbold JF, Johnson JS, Marchesi JR. Koutoukidis DA, et al. Gut Microbes. 2024 Jan-Dec;16(1):2392864. doi: 10.1080/19490976.2024.2392864. Epub 2024 Sep 28. Gut Microbes. 2024. PMID: 39340210 Free PMC article. - Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review.
Sosnowski K, Przybyłkowski A. Sosnowski K, et al. Gut Microbes. 2024 Jan-Dec;16(1):2393272. doi: 10.1080/19490976.2024.2393272. Epub 2024 Sep 3. Gut Microbes. 2024. PMID: 39224006 Free PMC article. Review. - Potential mechanism prediction of indole-3-propionic acid against diminished ovarian reserve via network pharmacology, molecular docking and experimental verification.
Liu A, Liu Z, Shen H, Du W, Jiang Y, Wang L, Zhang R, Jin P, Zhang X. Liu A, et al. BMC Complement Med Ther. 2024 Aug 27;24(1):316. doi: 10.1186/s12906-024-04611-1. BMC Complement Med Ther. 2024. PMID: 39192219 Free PMC article. - Game of microbes: the battle within - gut microbiota and multiple sclerosis.
Turner TA, Lehman P, Ghimire S, Shahi SK, Mangalam A. Turner TA, et al. Gut Microbes. 2024 Jan-Dec;16(1):2387794. doi: 10.1080/19490976.2024.2387794. Epub 2024 Aug 8. Gut Microbes. 2024. PMID: 39114974 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials